UBS Group’s Pliant Therapeutics PLRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.33M Sell
1,057,954
-4,661
-0.4% -$5.88K ﹤0.01% 5324
2025
Q4
$1.3M Sell
1,062,615
-259,402
-20% -$390K ﹤0.01% 5360
2025
Q3
$1.96M Sell
1,322,017
-1,324,539
-50% -$2.02M ﹤0.01% 4972
2025
Q2
$3.07M Buy
2,646,556
+1,010
+0% +$1.43K ﹤0.01% 4369
2025
Q1
$3.57M Buy
2,645,546
+2,017,265
+321% +$12.2M ﹤0.01% 4139
2024
Q4
$8.27M Buy
628,281
+397,973
+173% +$5.43M ﹤0.01% 3271
2024
Q3
$2.58M Buy
230,308
+78,106
+51% +$977K ﹤0.01% 3747
2024
Q2
$1.64M Sell
152,202
-212,862
-58% -$2.74M ﹤0.01% 3974
2024
Q1
$5.44M Buy
365,064
+22,891
+7% +$378K ﹤0.01% 2886
2023
Q4
$6.2M Buy
342,173
+71,369
+26% +$1.09M ﹤0.01% 2543
2023
Q3
$4.7M Buy
270,804
+267,780
+8,855% +$4.64M ﹤0.01% 2634
2023
Q2
$54.8K Sell
3,024
-11,536
-79% -$273K ﹤0.01% 6417
2023
Q1
$387K Buy
14,560
+9,165
+170% +$261K ﹤0.01% 4891
2022
Q4
$104K Sell
5,395
-1,205
-18% -$25.2K ﹤0.01% 6057
2022
Q3
$138K Buy
6,600
+3,063
+87% +$58.6K ﹤0.01% 5425
2022
Q2
$28K Buy
3,537
+550
+18% +$3.52K ﹤0.01% 6474
2022
Q1
$21K Sell
2,987
-7,334
-71% -$74.8K ﹤0.01% 7398
2021
Q4
$140K Buy
10,321
+8,391
+435% +$133K ﹤0.01% 5986
2021
Q3
$32K Buy
1,930
+533
+38% +$11.3K ﹤0.01% 6694
2021
Q2
$41K Buy
1,397
+501
+56% +$15.6K ﹤0.01% 6615
2021
Q1
$35K Sell
896
-483
-35% -$15.7K ﹤0.01% 6882
2020
Q4
$32K Sell
1,379
-1,131
-45% -$28.4K ﹤0.01% 6579
2020
Q3
$57K Buy
+2,510
New +$62.7K ﹤0.01% 5550

Other funds holding PLRX